Mechanisms of naringenin-induced apoptotic cascade in cancer cells: Involvement of estrogen receptor α and β signalling

IUBMB Life

Volumn 56, Issue 8, 2004, Pages 491-499

  Totta, Pierangela ^a   Acconcia, Filippo ^a   Leone, Stefano ^a   Cardillo, Irene ^a   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

Apoptotic cascade; Cancer cells; Estrogen receptor isoform activity; Naringenin

Indexed keywords

CASPASE 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HEPG2; COLON ADENOCARCINOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; MEDITERRANEAN DIET; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVANONES; HELA CELLS; HUMANS; IMMUNOBLOTTING; MODELS, CHEMICAL; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 9744284211     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400010792     Document Type: Article

References (41)

1. Hollman, P. C. H., and Katan, M. B. (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37, 937-942.
2. Cohen, J., Kristal, A., and Stanford, J. (2000) Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer. Inst. 92, 61-68.
3. Birt, D. F., Hendrich, S., and Wang, W. (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90, 157-177.
4. Kris-Etherton, P. M., Hecker, K. D., Bonanome, A., Coval, S. M., Binkoski, A. E., Hilpert, K. F., Griel, A. E., and Etherton, T. D. (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular dicease and cancer. Am. J. Med. 113, 71S-88S.
5. Constantinou, A. I., Kamath, N., and Murley, J. S. (1998) Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer 34, 1927-1934.
6. Keinan-Boker, L., van Der Schouw, Y. T., Grobbee, D. E., and Peelers, P. H. (2004) Dietary phytoestrogens and breast cancer risk. Am. J. Clin. Nutr. 79, 282-288.
7. Ozasa, K., Nakao, M., Watanabe, Y., Hayashi, K., Miki, T., Mikarai, K., Mori, M., Sakauchi, F., Washio, M., Ito, Y., et al. (2004) Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci. 95, 65-71.
8. Verhoeyen, M. E., Bovy, A., Collins, G., Muir, S., Robinson, S., de Vos, C. H., and Colliver, S. (2002) Increasing antioxidant levels in tomatoes through modification of the flavonoids biosynthetic pathway. J. Exp. Biol. 53, 2099-2106.
9. Bugianesi, R., Salucci, M., Leonardi, C., Ferracane, R., Catasta, G., Azzini, E., and Maiani, G. (2004) Effect of domestic cooking on human bioavailability of naringenin, chlorogenic acid, lycopene and beta-carotene in cherry tomatoes. Eur. J. Nutr. Apr 5, in press.
10. Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., and Yano, M. (1999) Quantitation of flavonoids constituents in citrus fruits. J. Agric. Food Chem. 47, 3565-3571.
11. Frydoonfar, H. R., McGrath, D. R., and Spiegelman, A. D. (2002) The variable effect on proliferation of a colon cancer cell line by citrus fruit flavonoid naringenin. Colorectal Disease 5, 149-152.
12. Virgili, F., Acconcia, F., Ambra, R., Rinna, A., Totta, P., and Marino, M. (2004) Nutritional flavonoids modulate estrogen receptor α signaling. IUBMB Life 56, 145-151.
13. Harmon, A. W., and Patel, Y. M. (2004) Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res. Treat. 85, 103-110.
14. Middleton, E., Kandaswami, C., and Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52, 673-751.
15. Harmon, A. W., and Patel, Y. M. (2003) Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 305, 229-234.
16. Kuiper, G. G. J. M., Carlsson, B., Grander, K., Enmark, E., Häggblad, J., Nilsson, S., and Gustafsson, J.-Å. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinol. 138, 863-870.
17. Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J.-Å. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinol. 139, 4252-4253.
18. 1 gene transcription in HepG2 cells. Mol. Biol. Cell 13, 3720-3729.
19. Ogawa, S., Inoue, S., Watanabe, T., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. (1998) Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 26, 3505-3512.
20. Marino, M., Acconcia, F., and Trentalane, A. (2003) Biphasic estradiol-induced AKT-phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell 14, 2583-2591.
21. Acconcia, F., Totta, P., Ogawa, S., Cardillo, I, Inoue, S., Leone, S., Trentalance, A., Muramatsu, M., and Marino, M. (2004) Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non-genomic signalling. J. Cell. Physiol., in press.
22. Moon, W. S., Chang, K., and Tarnawski, A. S. (2004) Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-α. Hum. Pathol. 35, 424-429.
23. Fiorelli, G., Picariello, L., Martinetti, V., Tonelli, F., and Brandi, M. L. (1999) Functional estrogen receptor β colon cancer cells. Biochem. Biophys. Res. Commun. 261, 521-527.
24. Di Leo, A., Messa, C., Cavallim, A., and Linsalata, M. (2001) Estrogens and colorectal cancer. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1, 1-12.
25. Bugianesi, R., Catasta, G., Spigno, P., D'Uva, A., and Maiani, G. (2002) Naringenin from cooked tomato paste is bioavailable in men. J. Nutr. 132, 3349-3352.
26. Felgines, C., Texier, O., Morand, C., Manach, C., Scalbert, A., Regerat, F., and Rémesy, C. (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. Am. J. Gastrointest. Liver Physiol. 279, G1148-G1154.
27. Brownson, D. M., Azios, N. G., Fuqua, B. K., Dharmawardhane, S. F., and Mabry, T. J. (2002) Flavonoid effects relevant to cancer. J. Nutr. 132, 3482S-3489S.
28. Adlercreut, H., Mazur, W., Stumpf, K., Kilkkinen, A., Pietinen, P., Hulten, K., and Hallmans, G. (2000) Food containing phytoestrogens, and breast cancer. Biofactors 12, 89-93.
29. Bors, W., Michel, C., and Stettmaier, K. (1997) Antioxidant effects of flavonoids. Biofactors 6, 399-402.
30. Ran, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
31. Badger, A. M., Bradbeer, J. N., Votta, B., Lee, J. C., Adams, J. L., and Griswold, D. E. (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Experimental Therapies 279, 1453-1461.
32. Kang, H. J., Soh, Y., Kim, M. S., Lee, E. J., Surh, Y. J., Kim, H. R., Kim, S. H., and Moon, A. (2003) Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in Ras-transformed human breast epithelial cells. Int. J. Cancer 103, 475-482.
33. Porras, A., Zuluaga, S., Black, E., Valladares, A., Alvarez, A. M., Ambrosino, C., Benito, M., and Nebreda, A. R. (2004) p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell. 15, 922-933.
34. Hall, J. M., McDonnell, D. P., and Korach, K. S. (2002) Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16, 469-486.
35. Jordan, C. V. (2003) Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J. Med. Chem. 46, 883-908.
36. Paige, L. A., Christensen, D. J., Gron, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C. Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β. Proc. Natl. Acad. Sci. USA 96, 3999-4004.
37. Rachez, C., and Freedman, L. P. (2001) Mediator complexes and transcription. Curr. Opin. Cell. Biol. 13, 274-280.
38. Brzezinski, A., and Debi, A. (1999) Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol. 85, 47-51.
39. Manolagas, S. C., Kousteni, S., and Jilka, R. L. (2002) Sex steroids and bone. Recent Prog. Horm. Res. 57, 385-409.
40. Kousteni, S., Han, L., Chen, J. R., Almeida, M., Plotkin, L. I., Bellido, T., and Manolagas, S. C. (2003) Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J. Clin. Invest. 111, 1651-1664.
41. Matthews, J., and Gustafsson, J.-A. (2003) Estrogen signalling: a subtle balance between ERα and ERβ. Mol. Interventions 3, 281-292.